section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Interactions

Drug-drug:

Drug-Natural Products:

Availability

(Generic available)

Route/Dosage

Hyperinsulinemic Hypoglycemia

US Brand Names

Proglycem

Action

  • Inhibits insulin release from the pancreas and decreases peripheral utilization of glucose.
Therapeutic effects:
  • Increased blood glucose.

Classifications

Therapeutic Classification: hyperglycemic

Pharmacologic Classification: pancreatics

Pharmacokinetics

Absorption: Well absorbed following oral administration.

Distribution: Crosses the blood-brain barrier and placenta.

Protein Binding: >90%.

Metabolism/Excretion: 50% metabolized by the liver; 50% excreted unchanged by the kidneys.

Half-Life: 10–36 hr ( in renal impairment).

Time/Action Profile

(Blood glucose concentrations)

ROUTEONSETPEAKDURATION
PO1 hr8–12 hr8 hr



Patient/Family Teaching

Pronunciation

dye-az-OX-ide